Skip to content
Review Open access

The Osteosarcoma Tumor Microenvironment: From Cellular Interactions to Advanced Preclinical Models

Sep 2026 · Cancers · Vol 18, pp. 2909 · 0 citations · 151 references
Medicine

TL;DR

This review summarizes the main preclinical models from spheroids to PDXs used to study OS and their ability to reproduce the tumor microenvironment, highlighting their importance for improving research and developing more effective therapies.

Abstract

Simple Summary Osteosarcoma (OS) is a rare and aggressive bone cancer that mainly affects children and adolescents. Developing new and effective treatments is challenging because OS is a complex disease that interacts with the tumor microenvironment. Preclinical models are essential for studying tumor biology, growth, metastasis, and responses to therapy before treatments are tested in patients. Several models, including 3D cell cultures, organoids, and animal models, are used to reproduce different aspects of OS. However, each model has specific advantages and limitations, and no single model can completely reproduce the complexity of the tumor. The tumor microenvironment, which includes immune cells, bone cells, blood vessels, and an extracellular matrix, plays an important role in tumor progression and treatment resistance. This review summarizes the main preclinical models from spheroids to PDXs used to study OS and their ability to reproduce the tumor microenvironment, highlighting their importance for improving research and developing more effective therapies.

Read PDF

Similar papers

Review Open access Oct 2026

The Osteosarcoma Tumor Microenvironment: Supportive of Tumor Progression, Hostile to Immunity, but Therapeutically Targetable

Simple Summary Osteosarcoma is the most common malignant bone tumor in children and adolescents. Although surgery and chemotherapy have improved the outcome of many patients, effective options remain limited for those with recurrent or metastatic disease. This restricted progress is not explained only by the biology of...

L. Tarone, I. Merighi, E. Tirtei et al. · 0 citations
Review 2026

Modeling the Melanoma Tumor Microenvironment: From 3D Cultures to Predictive 4D In Vitro Platforms

This narrative review provides a critical overview of advanced melanoma modeling platforms, including scaffold-free and scaffold-based 3D systems, spheroids, patient-derived organoids, assembloids, bioprinted constructs, and microfluidic tumor-on-chip devices, together with 4D time-resolved approaches.

I. Belviso, F. Mazzeo, M. L. Motti · 0 citations
Review Open access Aug 2026

Glioma Pathogenesis and Treatment Modality: Novel Insights From Midkine Research.

Gliomas, the most common and aggressive primary tumors in the central nervous system, are characterized by high invasiveness and resistance to therapy, making them a major focus of neuro-oncology research. Although substantial progress has been achieved in elucidating their molecular underpinnings in recent years, effe...

Tian-Yuan Zhao, Xue-Hui Pang, Xiao-Nan Xi et al. · 0 citations
Open access Sep 2026

miR-424-5p Regulates Stem-like and Malignant Phenotypes in Osteosarcoma by Targeting FZD4

Investigation of the role of frizzled class receptor 4 in OS progression found that it is highly expressed in OS and is associated with poor prognosis, and miR-424-5p can regulate these tumor-promoting effects by targeting FZD4.

Jing-Jin Ma, Yi Yang, Tong Liu et al. · 0 citations

A Tissue Explant Model for Colon Cancer.

J. Epiney, Stefano Gussago, Pénélope Saint-Amour et al. · 0 citations
Review Open access Aug 2026

Three current approaches to preclinical oral squamous cell carcinoma research: a practical, stepwise framework integrating cell lines, organoids, and animal models.

Oral squamous cell carcinoma (OSCC) continues to be associated with a poor prognosis despite recent advances in surgical and adjuvant treatment. Although a variety of experimental models are available, no widely accepted or practical framework has combined cell lines, patient-derived organoids, and in vivo transplantat...

T. Maruyama, G. Matsuzaki · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.